This is certainly not the shareholder friendly capital raise that Marc promised, that's for sure but better than bankruptcy.
The way it was written I found the press release confusing. This is how I understand it. There are not enough authorized shares for the preferred conversion on day 1. Once shareholder approval is achieved, the 3.6% dividend stops and all holders will convert. So the PFD offering is just a temporary bridge to a common issuance. No mention of a redemption date on the preferred.
The regime at Cytori has done a great job of destroying shareholder value over the last few years. I wonder if KT Lim stepped in here and participated. Given the big fees paid to get this done to Roth and Maxim, I would doubt it.
True to form we have all been fucked by Cytori mangement. They should all choke on there adipose. Jason Kolbert now can be added to the scum bag list as he has show his true colors. was certainly not my idea of 10 times my wildest dreams and who knows how many years it will take to get there if ever. Worked so hard and long for all the money we lost.
Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology.
Im not clear on what you are talking about with regard to formatting errors.
Regarding Athena, put simply the agreement calls for a reduction in the PFD conversion rate if the FDA decision , expected on October 17th, results in a material delay in Athena. In other words, PFD investors are protected from an adverse FDA decision on Athena. So even though funding of Athena is not there at this point, Cytori does need positive FDA feedback if there is any hope for moving the share price up, IMHO. Same caveat applies to warrant strike price.